COXSACKIE B SERIES CF ANTIGENS— 510(k) K850003
Substantially EquivalentHillcrest Biologicals
FDA 510(k) clearance K850003 for COXSACKIE B SERIES CF ANTIGENS, Substantially Equivalent on 1985-03-05. Applicant: Hillcrest Biologicals.
Clearance details
- Applicant
- Hillcrest Biologicals
- Product code
- Code GNG
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Cypress, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.